Krystal Biotech Inc Earnings

Krystal Biotech Inc’s revenue jumped 36.65% since last year same period to $96.04Mn in the Q2 2025. On a quarterly growth basis, Krystal Biotech Inc has generated 8.91% jump in its revenue since last 3-months.

Krystal Biotech Inc’s net profit jumped 146.23% since last year same period to $38.33Mn in the Q2 2025. On a quarterly growth basis, Krystal Biotech Inc has generated 7.28% jump in its net profits since last 3-months.

Krystal Biotech Inc’s net profit margin jumped 80.19% since last year same period to 39.91% in the Q2 2025. On a quarterly growth basis, Krystal Biotech Inc has generated -1.5% fall in its net profit margins since last 3-months.

Krystal Biotech Inc’s price-to-earnings ratio after this Q2 2025 earnings stands at 29.83.

Krystal Biotech Inc’s earning per share (EPS) estimates for the current quarter stand at 1.16 - a -4.92% fall from last quarter’s estimates.

Krystal Biotech Inc’s earning per share (EPS) estimates for the current year stand at 1.16.

Krystal Biotech Inc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Krystal Biotech Inc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.